Poster Session D - Tuesday Morning
Category: Interventional Endoscopy
Delvise T. Fogwe, MD
Mayo Clinic
Rochester, MN
Baseline Characteristics | EUSD N =106 | PTD N = 111 | P value |
Age, years, median (IQR) | 60 (48-68) | 60 (55-68.5) | 0.09 |
Female, no. (%) | 52(49.1) | 59 (53.1) | 0.54 |
Laparoscopic surgery, no. (%) | 56 (52.8) | 34(30.6) | 0.002 |
Pancreatic pathology, no. (%) | |||
Ductal adenocarcinoma | 43 (31.1) | 40 (29.7) | |
Neuroendocrine tumor | 32 (30.2) | 33 (29.7) | |
Intraductal papillary mucinous neoplasm | 12 (11.3) | 8 (7.2) | |
Other* | 19 (17.9) | 30 (27.0) | |
Inpatient, no. (%) | 52 (49.1) | 92(82.9) | < 0.001 |
Presence of solid necrosis, no. (%) | 48 (45.3) | 11 (9.9) | < 0.001 |
Infected POPFC, no. (%) | 42 (39.6) | 30 (27.0) | 0.06 |
Maximum diameter in cm, Median (IQR) | 7.4 (5.2-10.0) | 6.7 (5.1-10.0) | 0.45 |
Time to drainage from surgery, days, median (IQR) | 27.0 (13.5-46.5) | 10.0 (7.00-18.3) | < 0.001 |
Clinical Outcomes | |||
Clinical success, no. (%) | 98 (92.5) | 85 (76.6) | 0.001 |
Technical success, no. (%) | 106(100) | 111(100) | |
Procedure related adverse events, no. (%) | 11(10.4) | 7 (6.3) | 0.28 |
Number of interventions, median (IQR) | 2 (2-4) | 4 (2-6) | < 0.001 |
Time to drain removal, days, median, (IQR) | 45.5 (31.5-73.0) | 37.0 (24.0-61.0) | 0.013 |
Recurrence, no. (%) | 8 (7.6) | 23 (20.7) | 0.007 |